Oslo - Delayed Quote NOK
Thor Medical ASA (TRMED.OL)
2.4000
-0.0550
(-2.24%)
At close: April 25 at 4:25:12 PM GMT+2
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jasper Kurth | Chief Executive Officer | 3.07M | -- | 1985 |
| Mr. Brede Ellingsæter | Chief Financial & Operating Officer | 1.92M | -- | -- |
| Dr. Sindre Hassfjell | Chief Technology Officer | 1.93M | -- | -- |
| Dr. Alf Bjørseth Ph.D. | Executive VP of Business Development & Strategic Advisor | 1.8M | -- | 1941 |
| Ms. Astrid Liland | Executive VP of HSEQ | 1.68M | -- | -- |
| Mr. Sven Røst | Vice President of Communications | -- | -- | -- |
Thor Medical ASA
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 9
Description
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It processes by separation of natural occurring radioactive decay products from thorium. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Corporate Governance
Thor Medical ASA’s ISS Governance QualityScore as of April 1, 2025 is 10. The pillar scores are Audit: 7; Board: 10; Shareholder Rights: 1; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 26, 2025 at 6:00 AM UTC
Thor Medical ASA Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
2QV0.F Chemomab Therapeutics Ltd.
1.0900
+2.83%
PBN.F Alterity Therapeutics Limited
0.0045
+12.50%
6XY.F HBM Holdings Limited
0.9000
+5.88%
FAB.L Fusion Antibodies plc
6.80
-9.09%
ELIC.ST Elicera Therapeutics AB (publ)
4.3500
+13.73%
FARN.L Faron Pharmaceuticals Oy
202.00
-0.25%
BIOVIC-B.ST Biovica International AB (publ)
0.6980
+9.06%
MEDCL.PA MedinCell S.A.
14.97
+0.13%
VVY.AS Vivoryon Therapeutics N.V.
1.7760
-1.88%
MDCLF MedinCell S.A.
6.98
0.00%